Literature DB >> 11253117

Successful xenografting of cryopreserved primary pancreatic cancers.

C Sorio1, A Bonora, S Orlandini, P S Moore, P Capelli, P Cristofori, G Dal Negro, P Marchiori, G Gaviraghi, M Falconi, P Pederzoli, G Zamboni, A Scarpa.   

Abstract

In order to assess the suitability of cryopreserved neoplastic tissues for xenografting into nude (nu/nu) mice, we compared the take rate in 28 samples of pancreatic ductal carcinoma. Eleven fresh samples were implanted in nu/nu mice, and 17 were frozen in cryopreserving solution and implanted at a later time. All samples were examined for the presence of neoplastic tissue in cryostat sections. A total of 15 tumors grew in the animals; five from the freshly implanted samples and ten from those cryopreserved. Ten xenografted tumors were characterized for alterations in p53, K-ras, and p16 genes, which were found in six, eight, and nine cases, respectively. Our results demonstrate that the take rate for xenografting is comparable between cryopreserved and fresh tissue samples. The procedure allows for the exchange of tumor material between institutions and permits the establishment of centralized facilities for the storage of an array of different primary tumor samples suitable for the production of in vivo models of cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11253117     DOI: 10.1007/s004280000343

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type.

Authors:  Tommy Ivanics; John R Bergquist; Gang Liu; Michael P Kim; Yaan Kang; Matthew H Katz; Mayrim V Rios Perez; Ryan M Thomas; Jason B Fleming; Mark J Truty
Journal:  Lab Invest       Date:  2018-03-08       Impact factor: 5.662

Review 2.  Patient-derived xenografts as in vivo models for research in urological malignancies.

Authors:  Takahiro Inoue; Naoki Terada; Takashi Kobayashi; Osamu Ogawa
Journal:  Nat Rev Urol       Date:  2017-02-21       Impact factor: 14.432

3.  Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening.

Authors:  Sandra Pérez-Torras; Anna Vidal-Pla; Rosa Miquel; Vanessa Almendro; Laureano Fernández-Cruz; Salvador Navarro; Joan Maurel; Neus Carbó; Pere Gascón; Adela Mazo
Journal:  Cell Oncol (Dordr)       Date:  2011-06-17       Impact factor: 6.730

4.  Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy.

Authors:  Vladia Monsurrò; Stefania Beghelli; Richard Wang; Stefano Barbi; Silvia Coin; Giovanni Di Pasquale; Samantha Bersani; Monica Castellucci; Claudio Sorio; Stefano Eleuteri; Andrea Worschech; Jay A Chiorini; Paolo Pederzoli; Harvey Alter; Francesco M Marincola; Aldo Scarpa
Journal:  J Transl Med       Date:  2010-01-29       Impact factor: 5.531

5.  Cryopreservation of human colorectal carcinomas prior to xenografting.

Authors:  Michael Linnebacher; Claudia Maletzki; Christiane Ostwald; Ulrike Klier; Mathias Krohn; Ernst Klar; Friedrich Prall
Journal:  BMC Cancer       Date:  2010-07-08       Impact factor: 4.430

6.  A novel cell line and xenograft model of ampulla of Vater adenocarcinoma.

Authors:  Claudio Sorio; Patrick S Moore; Maria Grazia Ennas; Cristina Tecchio; Antonio Bonora; Silvia Sartoris; Piera Balzarini; Piergiovanni Grigolato; Aldo Scarpa
Journal:  Virchows Arch       Date:  2003-12-16       Impact factor: 4.064

7.  Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.

Authors:  Stefan Fritz; Carlos Fernández-del Castillo; A John Iafrate; Mari Mino-Kenudson; Nancy Neyhard; Jennifer LaFemina; Amy Stirman; Andrew L Warshaw; Sarah P Thayer
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

8.  Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.

Authors:  Vincenzo Corbo; Rossana Ritelli; Stefano Barbi; Niccola Funel; Daniela Campani; Alberto Bardelli; Aldo Scarpa
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

9.  Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.

Authors:  Christina Susanne Mullins; Björn Schneider; Florian Stockhammer; Mathias Krohn; Carl Friedrich Classen; Michael Linnebacher
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

10.  Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods.

Authors:  Nicolette G Alkema; Tushar Tomar; Evelien W Duiker; Gert Jan Meersma; Harry Klip; Ate G J van der Zee; G Bea A Wisman; Steven de Jong
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.